Skip to main content
Published locations for TNBC: Neoadjuvant and adjuvant pembrolizumab prolongs EFS in KEYNOTE-522
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
TNBC: Neoadjuvant and adjuvant pembrolizumab prolongs EFS in KEYNOTE-522
User login
Username
Password
Reset your password
/content/tnbc-neoadjuvant-and-adjuvant-pembrolizumab-prolongs-efs-keynote-522
/hematology-oncology/article/252938/breast-cancer/tnbc-neoadjuvant-and-adjuvant-pembrolizumab
/breast-cancer-icymi/article/252938/breast-cancer/tnbc-neoadjuvant-and-adjuvant-pembrolizumab